[HTML][HTML] Inflammation and cardiovascular disease: From mechanisms to therapeutics

A Alfaddagh, SS Martin, TM Leucker, ED Michos… - American journal of …, 2020 - Elsevier
Inflammation constitutes a complex, highly conserved cascade of molecular and cellular
events. Inflammation has been labeled as “the fire within,” is highly regulated, and is critical …

Ceramides in autoimmune rheumatic diseases: existing evidence and therapeutic considerations for diet as an anticeramide treatment

I Alexandropoulou, MG Grammatikopoulou… - Nutrients, 2023 - mdpi.com
Autoimmune rheumatic diseases (AIRDs) constitute a set of connective tissue disorders and
dysfunctions with akin clinical manifestations and autoantibody responses. AIRD treatment …

[HTML][HTML] Extra-articular manifestations in psoriatic arthritis patients

R Peluso, S Iervolino, M Vitiello, V Bruner, G Lupoli… - Clinical …, 2015 - Springer
Psoriatic arthritis (PsA) is an inflammatory rheumatic disorder, associated with skin and/or
nail psoriasis. It has been included in the spondyloarthropathies (SpA) group, with which it …

A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in …

F Lopez-Jimenez, V Simha, RJ Thomas… - Mayo Clinic …, 2014 - Elsevier
Abstract The American College of Cardiology/American Heart Association (ACC/AHA) Task
Force on Practice Guidelines has recently released the new cholesterol treatment guideline …

JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis

S Singh, S Singh - International Immunopharmacology, 2020 - Elsevier
Rheumatoid arthritis is a world leading cause of musculoskeletal disease. With the
introduction of biological agents as treatment alternatives the clinical possibilities have …

Arterial stiffness and adult onset vasculitis: a systematic review

A Lo Gullo, C Giuffrida, C Morace, G Squadrito… - Frontiers in …, 2022 - frontiersin.org
Chronic inflammation represents the cornerstone of the raised cardiovascular (CV) risk in
patients with inflammatory rheumatic diseases (IRD), including vasculitis. Standardized …

Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis

G Tocci, D Goletti, V Marino, A Matucci… - Expert Opinion on …, 2016 - Taylor & Francis
Introduction: Many chronic rheumatic diseases have an inflammatory etiology, leading to
accelerated atherosclerosis and increased occurrence of vascular diseases. In rheumatoid …

[HTML][HTML] Cardiac conduction disturbances in rheumatologic disease: A cross-sectional study

L Gerges, K D'Angelo, D Bass… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Background: Cardiovascular abnormalities are common in patients with rheumatologic
disorders. Tachy-arrhythmias occur more frequently in these patients than the general …

Preliminary Study on Pulse Wave Changes in Patients with Inflammatory Arthropathies Treated with bDMARDs

M Gasparotto, G Di Pierro, B Toffoli, A Grillo… - Journal of Clinical …, 2024 - mdpi.com
Background: Patients with inflammatory arthropathies exhibit an increased cardiovascular
disease (CVD) risk as compared to the general population, which is not fully quantified by …

Cardio-rheumatology: the cardiovascular, pharmacological, and surgical risks associated with rheumatological diseases in women

SL Sommer, MI Kontaridis - Canadian Journal of Physiology …, 2024 - cdnsciencepub.com
Cardiovascular disease (CVD) remains the number one cause of death worldwide. Women
are at increased risk of death from CVD, but the mechanisms for how and why this occurs …